---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-041036"
form_type: "8-K"
ticker: "NSPR"
cik: "0001433607"
company_name: "InspireMD, Inc."
filed_at: "2024-10-15T23:59:59+00:00"
generated_at: "2026-05-30T14:30:45.260355+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# InspireMD establishes Miami global HQ; anticipates U.S. launch of CGuard Prime in H1 2025

## Summary
- New global headquarters in Miami, Florida to support anticipated U.S. launch of CGuard Prime carotid stent system.
- Company expects potential FDA approval and U.S. launch in first half of 2025.
- Lease for 10,782 sq ft office space with 64-month term; $500,000 security deposit.
- Building commercial teams and infrastructure to support U.S. market.
- Submitted final module of PMA to FDA on September 16, 2024.

## SEC filing metadata
- accession: 0001493152-24-041036
- form_type: 8-K
- ticker: NSPR
- cik: 0001433607
- company_name: InspireMD, Inc.
- filed_at: 2024-10-15T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1433607/000149315224041036/0001493152-24-041036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1433607/000149315224041036/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-041036
- JSON: https://secwatch.observer/filing/0001493152-24-041036.json
- Plain text: https://secwatch.observer/filing/0001493152-24-041036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.